HeartFlow Analysis vs prolaio eVO2peak Module
AI Verdict
Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if you require a highly accurate, non-invasive diagnostic assessment of coronary artery disease (CAD) based on standard CT scans. This tool is ideal for clinicians seeking detailed insights into coronary artery blockages, their functional impact (FFRct), and plaque characteristics to guide treatment decisions. It provides personalized 3D models and computational fluid dynamics for a comprehensive understanding of a patient's coronary health.
View HeartFlow Analysis →Choose prolaio eVO2peak Module if…
Choose prolaio eVO2peak Module if you need to estimate peak oxygen consumption (eVO2peak) using real-world patient data from wearable sensors for ongoing cardiovascular assessment or research. This software is best suited for clinicians and researchers looking for a non-invasive, longitudinal method to track cardiorespiratory fitness, especially in specialties like physical medicine, rehabilitation, or sports medicine, by processing data from qualified third-party FDA-cleared wearable medical sensors.
View prolaio eVO2peak Module →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | HeartFlow Analysis | prolaio eVO2peak Module |
|---|---|---|
| Pricing | Contact vendor for pricing | Contact for pricing |
| Deployment | Cloud-based (AWS) | Cloud-based (software-only, processes remote sensor data) |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | HeartFlow Analysis | prolaio eVO2peak Module |
|---|---|---|
| Name | HeartFlow Analysis | prolaio eVO2peak Module |
| Company | HeartFlow | Prolaio |
| Description | Commercial-stage medical technology company providing software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries from standard CT scans. | A clinical intelligence company that develops FDA-cleared software, such as the eVO2peak Module, to estimate peak oxygen consumption using real-world patient data for cardiovascular research and care. |
| Tagline | Decisive Coronary Care | Heart care, connected. |
| Key Features | AI-powered 3D modeling of coronary arteries, Fractional Flow Reserve derived from CT (FFRct) analysis, Plaque Analysis (quantification and characterization), Roadmapu2122 Analysis for CCTA reading, Non-invasive diagnostic assessment, Personalized patient insights, Computational Fluid Dynamics (CFD) for blood flow simulation, High diagnostic accuracy | Estimates peak oxygen consumption (eVO2peak), Utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs, Processes data from qualified third-party FDA-cleared wearable medical sensors, Applies a locked deep-learning model for eVO2peak estimation, Provides information as an adjunctive aid in clinical evaluation, Enables high-density, longitudinal data collection, Leverages real-world patient data and insights, Features FDA-cleared software and proprietary algorithms |
Videos
Demos, reviews, and walkthroughs featuring HeartFlow Analysis and prolaio eVO2peak Module.